Skip to main content

Table 4 Risk of bias assessment of RCT:

From: The effects of several postoperative adjuvant therapies for hepatocellular carcinoma patients with microvascular invasion after curative resection: a systematic review and meta-analysis

  Random sequence generation Allocation concealment Blinding of participants and personnel Blinding of outcome Incomplete outcome data Selective reporting Other bias
Wei, 2018 [15] Low risk Unclear risk Low risk Low risk Low risk Low risk Low risk
  1. RCT randomized clinical trial